Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Lyophilisation: Freeze-Drying in Pharmaceuticals and Biopharmaceuticals

25 Feb 2013 - 26 Feb 2013 - London, UK



Bookmark and Share


SMi is proud to present their inaugural conference on Lyophilisation: Freeze-drying in pharmaceuticals & Biopharmaceuticals, with key talks from Medimmune, GSK Biologicals, National Institute for Biological Standards & Control and Roche on the best practices, novel discoveries and industry innovations that are essential to the development of a company’s lyophilisation process. This conference is not to be missed as this is the forum for you to learn, explore and discover the cutting edge areas of the industry, and the essential ways a company can improve its freeze drying methods.

Benefits of attending include:                                                                         Learn of formulation techniques that assist in the lyophilisation process, and how to apply these to your own technical issues

·         Explore the latest research and development in the industry, and how these have led to improved lyophilisation cycles, both pre, and post up-scaling

·         Discover the potential technical and logistical difficulties encountered in all levels of the lyophilisation process

·         Consider the regulations in chemical engineering and how compliance can be achieved

·         Examine previous examples of up-scaling in the industry, and how to apply these to your own freeze-drying process

·         Hear about regulations, monitoring and risk reduction, to improve the cost effectiveness of the cycle, and how these can be used to manage risks and adapt to the problems encountered

Key speakers include:

 Yves Mayeresse, Director of Manufacturing, GSK Biologicals

·         Sajal Patel, Scientist II, MedImmune

·         Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim

·         Paul Matejtschuk, Principal Scientist, National Institute For Biological Standards & Control

Sune Klint Andersen, Principal Scientist Drying Processes, Novo Nordisk A/s          

       Jean René Authelin, Global Head of Pharmaceutical Engineering, Pharmaceutical Sciences, Sanofi R&D

·         Ahmad Abdul-Fattah, Group Leader, Late Stage Pharmaceutical and Processing Development, Roche

 Register at http://www.smi-online.co.uk/goto/lyophilisation-conference.asp

Or alternatively contact Annie Blundell on tel +44 (0)20 7827 6090 or email: ablundell@smi-online.co.uk



Further information
Scientific News
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
New Diabetes Drug has Unexpected Side Effect
A type of drug used to treat diabetes may reduce the risk of developing Parkinson’s disease, according to new research.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Cannabis May Be Used to Treat Fractures
TAU researcher finds non-psychotropic compound in marijuana can help heal bone fissures.
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Creating More Potent Vaccines
Yale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity.
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Global Search for Next Antibiotic
University of Queensland researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!